| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2106 | 2003 |
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study Data Collection on Adverse Events of Anti-HIV Drugs Study Group Archives of internal medicine 166 (15), 1632-1641, 2006 | 1490 | 2006 |
| Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration D: A: D Study Group The Lancet 371 (9622), 1417-1426, 2008 | 1162 | 2008 |
| Factors associated with specific causes of death amongst HIV-positive individuals in the D: A: D Study Data Collection on Adverse Events of Anti-HIV drugs (D: A: D) Study Group Aids 24 (10), 1537-1548, 2010 | 562 | 2010 |
| Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial JU Jensen, L Hein, B Lundgren, MH Bestle, TT Mohr, MH Andersen, ... Critical care medicine 39 (9), 2048-2058, 2011 | 485 | 2011 |
| Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial JU Jensen, L Hein, B Lundgren, MH Bestle, TT Mohr, MH Andersen, ... Critical care medicine 39 (9), 2048-2058, 2011 | 474 | 2011 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 471 | 2011 |
| Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ... European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010 | 439 | 2010 |
| Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study … A Mocroft, JD Lundgren, ML Sabin, AA Monforte, N Brockmeyer, ... PLoS medicine 10 (9), e1001510, 2013 | 388 | 2013 |
| Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ... The Journal of infectious diseases 207 (9), 1359-1369, 2013 | 369 | 2013 |
| A multi-disciplinary perspective on emergent and future innovations in peer review JP Tennant, JM Dugan, D Graziotin, DC Jacques, F Waldner, D Mietchen, ... F1000Research 6, 2017 | 287 | 2017 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 286 | 2005 |
| Cardio-and cerebrovascular events in HIV-infected persons Writing Committee Aids 18 (13), 1811-1817, 2004 | 277 | 2004 |
| y CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE J Young, M Psichogiou, L Meyer, S Ayayi, S Grabar, F Raffi, P Reiss, ... PLoS Medicine 9 (3), 2012 | 200 | 2012 |
| Long-term mortality in HIV-positive individuals virally suppressed for> 3 years with incomplete CD4 recovery FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, ... Clinical infectious diseases 58 (9), 1312-1321, 2014 | 194 | 2014 |
| Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen A Cozzi-Lepri, AN Phillips, L Ruiz, B Clotet, C Loveday, J Kjaer, H Mens, ... Aids 21 (6), 721-732, 2007 | 142 | 2007 |
| The incidence of AIDS-defining illnesses at a current CD4 count≥ 200 cells/µL in the post–combination antiretroviral therapy era A Mocroft, HJ Furrer, JM Miro, P Reiss, C Mussini, O Kirk, S Abgrall, ... Clinical infectious diseases 57 (7), 1038-1047, 2013 | 133 | 2013 |
| Risk of triple-class virological failure in children with HIV: a retrospective cohort study H Castro, A Judd, DM Gibb, K Butler, RK Lodwick, A van Sighem, ... Lancet 377 (9777), 1580, 2011 | 128 | 2011 |
| Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study Collaboration of Observational HIV Epidemiological Research Europe (COHERE ... Antiviral therapy 14 (8), 1065-1074, 2009 | 111 | 2009 |
| Real‐world evidence in EU medicines regulation: enabling use and establishing value P Arlett, J Kjær, K Broich, E Cooke Clinical pharmacology and therapeutics 111 (1), 21, 2022 | 110 | 2022 |
